VANGUARD GROUP INC

Holdings History for Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX)

Symbol: ELTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$3,955,331	496,901	+23,042	+4.9%	$7.96	Q4 2025
30 Sep 2025	0%	+0%	$5,184,017	473,859	+19,240	+4.2%	$10.94	Q3 2025
30 Jun 2025	0%	+0%	$3,509,658	454,619	+132,925	+41%	$7.72	Q2 2025
31 Mar 2025	0%	+0%	$1,981,635	321,694	+75,871		$6.16	Q1 2025
31 Dec 2024	0%	0%	$1,204,533	245,823	+561	+0.23%	$4.90	Q4 2024
30 Sep 2024	0%	+0%	$1,233,667	245,262	+18,965	+8.4%	$5.03	Q3 2024
30 Jun 2024	0%	+0%	$930,080	226,297	+10,611	+4.9%	$4.11	Q2 2024
31 Mar 2024	0%	+0%	$1,639,214	215,686	+40,792	+23%	$7.60	Q1 2024
31 Dec 2023	0%	+0%	$1,458,616	174,894	+34,367	+24%	$8.34	Q4 2023
30 Sep 2023	0%	+0%	$1,187,453	140,527	+69,777	+99%	$8.45	Q3 2023
30 Jun 2023	0%	+0%	$672,125	70,750	+70,750	NEW	$9.50	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.